OBAMA 2008:”I’LL FIX EVERYTHING-IT’S EASY” OBAMA 2011″IT’S SO BAD I NEED MORE TIME”-WHICH IS the BIGGER LIE?
Question by AntiPc-inHD: OBAMA 2008:”I’LL FIX EVERYTHING-IT’S EASY” OBAMA 2011″IT’S SO BAD I NEED MORE TIME”-WHICH IS THE BIGGER LIE?
In order to get elected in 2008 the President campaigned on how intelligent he was-and due to that he could fix everything…..fix the economy-fix secret back door meetings-fix too many lobbyists-fix Iran issues. So enough people bought the goods he was selling to get him elected. NOW that appears his presidency failed-he and his minions have changed their tune to: “We didn’t know it was this bad-so give us four more years.” If he was so smart as he promised to get elected-why DIDN’T he know it was “this bad.”? Isn’t the truth that the honest 2011 campaign should say “We didn’t know that we don’t know what we’re doing?”
Best answer:
Answer by Jimmy Whispers MMXII
Yes, i agree his statement of 2008 was unrealistic and so is much of his views, but try listening to his competitors speak, they’re the most unrealistic bunch I’ve ever seen.
Give your answer to this question below!
New Test Increases Diagnoses of Drug-Resistant TB and Shortens Time to …
Filed under: drug treatment news 2011
“This new TB test is helping expose the true size of the drug-resistant TB epidemic and get people on treatment faster,” said Dr. Helen Bygrave, HIV/TB specialist with MSF in South Africa. “But patients and doctors alike still struggle with the long …
Read more on eNews Park Forest
Synergy Pharmaceuticals Reports Third Quarter 2012 Financial Results
Filed under: drug treatment news 2011
NEW YORK, Nov. 13, 2012 (GLOBE NEWSWIRE) — Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financial results and business update for the third quarter and nine …
Read more on Equities.com
Is This Diabetes Drug Merck's Next Blockbuster?
Filed under: drug treatment news 2011
The company's diabetes franchise of Januvia and Janumet offers some stability, with more than $ 1.4 billion in revenue last quarter and $ 4.7 billion in 2011. But those drugs have patents, too, and the clock is ticking for a new diabetes treatment. Could …
Read more on Motley Fool